Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts is a teaching hospital of Harvard Medical School. Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. It is one of the largest hospitals in New England, is affiliated with Joslin
Diabetes Center and is a member of Dana-Farber/Harvard
Cancer Center, the largest
cancer institution in the country. The President and CEO of BIDMC is Kevin Tabb, MD, who assumed the role in October 2011. Tabb came to BIDMC from Stanford Hospital & Clinics in Stanford, CA where he was the Chief Medical Officer (CMO). On October 3, 2011 Beckers Hospital Review listed BIDMC among the "70 Hospitals with Great
Cardiology Programs." Since the merger, the hospital has consisted of two campuses, the East (former Beth Israel) and the West (former Deaconess).The East Campus retained most primary care, outpatient, clinical and administrative functions, while the emergency department, inpatient care, the department of human resources, and many specialists are located on the West Campus.
Last Updated on: Sep 24, 2024